- Home
- ยป
- Our Products
- »
- Pharma Tablets
Pharma Tablets
Pioglitazone Tablets IP
Product Brochure
Form | Tablet |
Composition | Pioglitazone Tablets |
Brand | Piosteris 30 |
Pacakage | 10x10 |
Country of Origin | Made in India |
Pioglitazone Tabletsis used with a diet and exercise program and sometimes with other medications, to treat type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood). Pioglitazone Tablets is in a class of medications called thiazolidinediones.
Temozolamide 250 Mg
Minimum Order Quantity: 1 Bottle
Product Brochure
Manufacturer | Steris Healthcare |
Packaging Size | 1X5 |
Brand | TMOZOLMIDE 250 |
Composition | Temozolamide 250 Mg |
Prescription/Non prescription | Prescription |
Form | Tablet |
Product Name | TMOZOLMIDE 250 |
Temozolamide 100 mgTemozolomide is an alkylating agent used to treat serious brain cancers; most commonly as second-line treatments for astrocytoma and as the first-line treatment for glioblastoma. Olaparib in combination with temozolomide demonstrated substantial clinical activity in relapsed small cell lung cancer.
Dapagliflozin (5mg), Metformin (500mg
Packaging Type | Stripe |
Manufacturer | Steris Healthcare Pvt Ltd |
Prescription / Non Prescription | Prescription |
Also gives | PCD Pharma Franchise |
Country of Origin | Made in India |
Glidapaflozin
The combination of Dapagliflozin (5 mg) and Metformin (500 mg) is utilized in the treatment of type 2 diabetes mellitus to improve blood sugar control in adults. This combination offers a dual approach by targeting different pathways involved in glucose metabolism.
Dapagliflozin is a type of medication known as a sodium-glucose cotransporter 2 (SGLT2) inhibitor. It works by helping the kidneys to remove glucose from the bloodstream through the urine. This mechanism not only aids in lowering blood glucose levels but can also offer additional benefits such as weight loss and potentially reduced blood pressure. The 5 mg dosage is typically used as a starting dose to assess effectiveness and tolerability before possibly adjusting it based on the patient's response.
Metformin, a biguanide, is one of the most commonly prescribed medications for type 2 diabetes. It acts by decreasing glucose production in the liver, improving insulin sensitivity, and increasing glucose uptake by the muscles. The 500 mg dose of Metformin can be considered a starting point, often taken twice a day or as directed by a healthcare provider, and may be adjusted based on the patient's needs and tolerance to the medication.
The combination of Dapagliflozin and Metformin in a single treatment regimen offers a comprehensive approach by not only improving insulin sensitivity and reducing hepatic glucose production (via Metformin) but also by eliminating excess glucose through the urine (via Dapagliflozin). This synergistic effect can enhance glycemic control more effectively than either medication alone.
Patients on this combination therapy should closely monitor their blood sugar levels and follow their healthcare provider's advice regarding diet and exercise. Possible side effects may include urinary tract infections and genital infections due to the mode of action of Dapagliflozin, as well as gastrointestinal symptoms from Metformin, such as nausea or diarrhea. A rare but serious risk of Metformin is lactic acidosis, especially in patients with kidney problems or other conditions that might predispose them to it.
As with any diabetes management plan, regular follow-ups with a healthcare provider are important to adjust the treatment as necessary and to monitor for any potential side effects or complications.